FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称COPANLISIB
异名/同义词2-AMINO-N-(7-METHOXY-8-(3-(MORPHOLIN-4-YL)PROPOXY)-2,3-DIHYDROIMIDAZO(1,2-C)QUINAZOLIN-5-YL(PYRIMIDINE-5-CARBOXAMIDE
2-AMINO-N-(7-METHOXY-8-(3-MORPHOLIN-4-YLPROPOXY)-2,3-DIHYDROIMIDAZO(1,2-C)QUINAZOLIN-5-YL)PYRIMIDINE-5-CARBOXAMIDE
5-PYRIMIDINECARBOXAMIDE, 2-AMINO-N-(2,3-DIHYDRO-7-METHOXY-8-(3-(4-MORPHOLINYL)PROPOXY)IMIDAZO(1,2-C)QUINAZOLIN-5-YL)-
BAY 80-6946
BAY80-6946
BAY-80-6946
COPANLISIB
COPANLISIB [INN]
COPANLISIB [MI]
COPANLISIB [USAN]
COPANLISIB [WHO-DD]
CAS登记号1032568-63-0
物质唯一标识(Unique Ingredient Identifier)WI6V529FZ9
分子式C23H28N8O4
国际化合物标识(International Chemical Identifier,InChI)PZBCKZWLPGJMAO-UHFFFAOYSA-N
SMILESc1(cnc(N)nc1)C(=O)NC=2N3CCN=C3c4c(c(c(cc4)OCCCN5CCOCC5)OC)N2
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System